Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice 247 Apr 19, 2021 35.00 -1.41   
 24Storage 24STOR Apr 19, 2021 43.50 +2.84   
 2cureX 2CUREX Apr 19, 2021 19.18 +0.21   
 AAC Clyde Space AAC Apr 19, 2021 2.61 -0.38   
 AAK AAK Apr 19, 2021 201.40 +0.45   
 ABB ABB Apr 19, 2021 278.50 -0.89   
 Abelco Investment Group ABIG Apr 19, 2021 0.12 0.00   
 Abera Bioscience ABERA Apr 19, 2021 12.75 0.00   
 ABG Sundal Collier Holding ABGO Apr 19, 2021 9.00 0.00   
 Abliva ABLI Apr 19, 2021 0.75 -0.53   
 Absolent Group ABSO Apr 19, 2021 405.00 +1.25   
 Absolicon ABSL Apr 19, 2021 137.50 +1.48   
 AcadeMedia ACAD Apr 19, 2021 90.20 +0.78   
 Acarix ACARIX Apr 19, 2021 1.56 -6.71   
 Acconeer ACCON Apr 19, 2021 42.30 -5.37   
 Acosense ACOS Apr 19, 2021 1.86 -4.38   
 AcouSort ACOU Apr 19, 2021 23.95 -4.20   
 ACQ Bure ACQSPAC 0.00 0.00   
 Acrinova A ACRIA Apr 19, 2021 11.62 0.00   
 Acrinova B ACRIB Apr 19, 2021 13.20 0.00   
 ACROUD ACROUD Apr 19, 2021 3.89 +4.29   
 Actic Group ATIC Apr 19, 2021 17.05 -0.87   
 Active Biotech ACTI Apr 19, 2021 1.50 +1.49   
 AcuCort ACUC Apr 19, 2021 4.73 -2.87   
 Adapteo ADAPT Apr 19, 2021 116.20 +0.35   
 AdderaCare ADDERA Apr 19, 2021 7.58 +2.99   
 AddLife B ALIFB Apr 19, 2021 213.20 +0.28   
 Addnode Group B ANODB Apr 19, 2021 281.50 0.00   
 Addtech B ADDTB Apr 19, 2021 150.00 0.00   
 ADDvise Group A ADDVA Apr 19, 2021 3.17 -1.55   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK